Overview
Mihir Shah is an Oncologist and a General Surgeon in Philadelphia, Pennsylvania. Dr. Shah is rated as an Experienced provider by MediFind in the treatment of Obstructive Uropathy. His top areas of expertise are Enlarged Prostate (BPH), Urothelial Cancer, Non-Muscle Invasive Bladder Cancer, Ureteroscopy, and Prostatectomy. Dr. Shah is currently accepting new patients.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- PPO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE SNP
- MEDICARE MAPD
- OTHER MEDICARE
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE SNP
- OTHER MEDICARE PART D
- HMO
- POS
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- EPO
- HMO
- PPO
- EPO
- POS
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- HMO
- MANAGED MEDICAID PLAN
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- EPO
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
1101 Chestnut Street, Floor 11, Philadelphia, PA 19107
2211 Chapel Avenue West, Suite 301, Cherry Hill, NJ 08002
Additional Areas of Focus
Dr. Shah has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Lee Schachter is an Oncologist and an Urologist in Abington, Pennsylvania. Dr. Schachter is rated as a Distinguished provider by MediFind in the treatment of Obstructive Uropathy. His top areas of expertise are Congenital Mesoblastic Nephroma, Obstructive Uropathy, Chromophobe Renal Cell Carcinoma, Ureteroscopy, and Reconstructive Urology Surgery. Dr. Schachter is currently accepting new patients.
Jefferson Health – Navy Yard
Jeanne Llenado is an Oncologist and a General Surgeon in Philadelphia, Pennsylvania. Dr. Llenado is rated as a Distinguished provider by MediFind in the treatment of Obstructive Uropathy. Her top areas of expertise are Hydronephrosis, Urinary Tract Infection in Children, Boils, Obstructive Uropathy, and Ureteroscopy. Dr. Llenado is currently accepting new patients.
BuxMont Urological Specialists - Plymouth Meeting
Matthew Gerstein is an Oncologist and an Urologist in Plymouth Meeting, Pennsylvania. Dr. Gerstein is rated as a Distinguished provider by MediFind in the treatment of Obstructive Uropathy. His top areas of expertise are UPJ Obstruction, Diphallia, Perirenal Abscess, Ureteroscopy, and Prostatectomy. Dr. Gerstein is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Enlarged Prostate (BPH)Dr. Shah isAdvanced. Learn about Enlarged Prostate (BPH).
- Urothelial CancerDr. Shah isAdvanced. Learn about Urothelial Cancer.
- Experienced
- Bilateral HydronephrosisDr. Shah isExperienced. Learn about Bilateral Hydronephrosis.
- Bladder CancerDr. Shah isExperienced. Learn about Bladder Cancer.
- BoilsDr. Shah isExperienced. Learn about Boils.
- CarbuncleDr. Shah isExperienced. Learn about Carbuncle.
- Chromophobe Renal Cell CarcinomaDr. Shah isExperienced. Learn about Chromophobe Renal Cell Carcinoma.
- Clear Cell SarcomaDr. Shah isExperienced. Learn about Clear Cell Sarcoma.